GLP-1 in Serbia 2026: RFZO Access and Private Options

This article describes current GLP-1 medication access in Serbia based on publicly available RFZO policy and market information. It is educational, not medical advice.

Quick answer

Serbia has more structured public access to GLP-1 medications than many countries in the region. Ozempic is on the RFZO (Republic Health Insurance Fund) list with a 50 dinar participation fee, but access is restricted to type 2 diabetes patients with specific criteria: excess body weight and prior failure of other diabetes treatments. Wegovy and Rybelsus are also approved in Serbia. Prescribing requires endocrinologist or internist sign-off, and continued treatment requires a 6-month effectiveness check showing at least 0.5% HbA1c reduction or 3% weight loss.

You are in Serbia, considering GLP-1 medication, and trying to understand: can I get it through public health, what does it actually cost, and what does the process look like? Serbia's approach is one of the more structured in the region. RFZO covers Ozempic for specific patients, but the criteria are narrow.

What is available in Serbia

Three semaglutide-based products and tirzepatide are available in Serbia:

Ozempic (semaglutide) for type 2 diabetes
Wegovy (semaglutide, higher-dose formulation) for weight management
Rybelsus (oral semaglutide tablet) for type 2 diabetes
Mounjaro (tirzepatide) is increasingly available in private channels

All require a prescription from a Serbian-licensed physician.

RFZO reimbursement: the structured pathway

This is what sets Serbia apart in the region. Ozempic is included on the RFZO list of reimbursed medications, with patients paying only a 50 dinar (RSD) participation fee. That is a significant savings compared to private retail pricing.

The catch: access is conditional. To qualify for RFZO-reimbursed Ozempic, a patient must:

Have a documented type 2 diabetes diagnosis
Have excess body weight
Have already tried other diabetes medications without adequate results
Receive a prescription from an endocrinologist or internist (not a general practitioner alone)

After six months of treatment, RFZO requires an effectiveness assessment. Treatment can continue only if:

HbA1c has decreased by at least 0.5%, OR
Weight has decreased by at least 3%

This is one of the more rigorous outcome-based reimbursement frameworks in Europe.

Wegovy and weight management access

Wegovy is approved and available in Serbia, but RFZO does not reimburse it for weight management. Most Wegovy access in Serbia is private pay, similar to how it works in Hungary and many other Central European markets.

People pursuing weight loss with GLP-1 medication in Serbia typically:

Book a private endocrinologist consultation
Get lab work done (HbA1c, fasting glucose, lipid panel, thyroid)
Receive a prescription if appropriate
Fill at a private pharmacy
Pay out of pocket

Approximate pricing in Serbia

Medication	Approximate monthly cost (RSD)	Notes
Ozempic via RFZO (qualifying T2D patients)	50 RSD participation fee	Highly subsidized
Ozempic private retail	15,000 to 25,000 RSD	Depends on dose strength
Wegovy	30,000 to 60,000 RSD	Private pay only
Rybelsus	Varies by dose strength	Oral; may be partially reimbursed for T2D
Mounjaro	Variable; less established pricing	Private pay

These ranges reflect publicly reported pricing across private pharmacies in Belgrade and Novi Sad. Pricing varies by pharmacy and supply.

The prescription pathway

For RFZO-reimbursed Ozempic:

Visit your izabrani lekar (chosen primary care doctor) for a referral
Endocrinologist or internist consultation
Specialist evaluates whether you meet RFZO criteria
Prescription issued if qualified
Fill at any pharmacy on the RFZO network
Six-month effectiveness assessment with the specialist

For private weight management:

Book directly with a private endocrinologist (no referral needed)
Lab work and consultation
Prescription
Fill at a private pharmacy
Follow-up consultations as advised

Belgrade has multiple private clinics specializing in metabolic health and GLP-1 prescribing. Novi Sad and other major Serbian cities have growing options.

Side effects to expect

GLP-1 medications cause similar side effects across the class. The most common, based on large user studies:

Side effect	About how often reported
Nausea	37%
Fatigue	17%
Vomiting	16%
Constipation	15%
Diarrhea	13%

Most side effects cluster in the first weeks after starting or after a dose increase. They usually taper as the body adapts.

What to track

If you are starting GLP-1 medication in Serbia, the most useful things to track:

Weekly weight, same morning, same conditions
Daily energy and mood
Nausea after dose changes
Bowel function
HbA1c reduction (the RFZO benchmark for continued reimbursement)
Lipid panel at scheduled lab checks
Any side effects worth flagging to your specialist

The Regimen app handles all of this with 50+ markers to choose from. You can log your HbA1c and other lab values over time so when your specialist runs the 6-month RFZO effectiveness check, you have a clear visual of your trend instead of trying to remember individual readings. Free for one compound. Available on iOS and Android in Serbia.

Frequently Asked Questions

Is Ozempic reimbursed by RFZO in Serbia?

Yes, for type 2 diabetes patients who meet specific criteria: excess body weight and prior failure of other diabetes medications. The participation fee is 50 RSD. Continued reimbursement requires a 6-month effectiveness check.

How much does Wegovy cost in Serbia?

Wegovy is private pay for weight management in Serbia. Approximate monthly cost ranges from 30,000 to 60,000 RSD depending on dose strength and pharmacy.

Do I need an endocrinologist referral?

For RFZO reimbursement of Ozempic, yes. Either an endocrinologist or internist must sign off. For private weight management prescriptions, you can typically book directly with a private endocrinologist without a GP referral.

What is the 6-month RFZO effectiveness check?

After six months on RFZO-reimbursed Ozempic, your specialist reassesses. Continued reimbursement requires HbA1c reduction of at least 0.5% or weight loss of at least 3%. If you have not hit either threshold, RFZO will not continue covering the medication.

Is Mounjaro available in Serbia?

Yes, Mounjaro is increasingly available through private channels. Pricing varies and is less established than Ozempic.

What about fake or counterfeit GLP-1 drugs?

The Serbian and broader regional market has seen counterfeit semaglutide products. Always purchase through licensed Serbian pharmacies and verify packaging. Sourcing from non-pharmacy channels carries real risks.

Does Regimen support Serbian users?

Yes. Regimen is available on iOS and Android in Serbia. The app tracks GLP-1 medications, integrates with Apple Health and Google Health Connect, and logs lab values like HbA1c which is especially useful for the RFZO 6-month check.